AIM
MED icon

Aigen Investment Management’s Medifast MED Stock Holding History

Aigen Investment Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,143
Closed -$103K – 704
2026
Q1 		$103K Buy
+10,143
New +$109K 0.03% 461
2024
Q1 		– Sell
-3,700
Closed -$249K – 888
2023
Q4 		$249K Buy
3,700
+199
+6% +$13.9K 0.04% 567
2023
Q3 		$262K Sell
3,501
-3,768
-52% -$334K 0.05% 571
2023
Q2 		$670K Buy
+7,269
New +$647K 0.1% 282
2022
Q3 		– Sell
-1,716
Closed -$310K – 685
2022
Q2 		$310K Sell
1,716
-819
-32% -$147K 0.05% 390
2022
Q1 		$433K Buy
+2,535
New +$478K 0.07% 303
2021
Q4 		– Sell
-1,241
Closed -$239K – 1122
2021
Q3 		$239K Buy
+1,241
New +$305K 0.05% 385
2020
Q1 		– Sell
-2,416
Closed -$265K – 1440
2019
Q4 		$265K Buy
+2,416
New +$234K 0.04% 474

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Aigen Investment Management's MED Position: Q2 2026 in Review

Aigen Investment Management sold out of Medifast (MED) in Q2 2026, closing a stake of 10,143 shares — an estimated $103K sold.

Aigen Investment Management first reported a position in MED in Q4 2019 and held it in 8 quarters. The position peaked at $670K in Q2 2023. 112 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Aigen Investment Management reported no remaining Medifast position as of Q2 2026 after selling out during the quarter.
  • Aigen Investment Management sold 10,143 Medifast shares in Q2 2026, an estimated $103K.
  • Aigen Investment Management first reported a position in Medifast in Q4 2019 and held it in 8 quarters.
  • Aigen Investment Management's Medifast position peaked at $670K in Q2 2023.
  • 112 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.